Publications by authors named "Y Cajal"

Claim this Profile
C
Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity.
Elena Sánchez-López, Laura Guzman, Roser Segovia, Marta Espina, Marcel Li Carbó, Yolanda Cajal

Int J Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-rich colistin and B-pure colistin as novel strategies to increase the therapeutic window of polymyxin antibiotic therapy.
Laura Guzman, Francesc Rabanal, Júlia Garcia, Ana Maria Marqués, Elena Sánchez, Yolanda Cajal

Biomed Pharmacother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin treatment causes neuronal loss and cognitive impairment via ros accumulation and neuronal plasticity alterations.
Laura Guzman, Antoni Parcerisas, Amanda Cano, Elena Sánchez-López, Ester Verdaguer, Yolanda Cajal

Biomed Pharmacother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of the Antimicrobial Peptide Murepavadin Using Novel Coupling Agents.
Júlia García-Gros, Yolanda Cajal, Ana Maria Marqués, Francesc Rabanal

Biomolecules· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linker-Free Synthesis of Antimicrobial Peptides Using a Novel Cleavage Reagent: Characterisation of the Molecular and Ionic Composition by nanoESI-HR MS.
Roser Segovia, Mireia Díaz-Lobo, Yolanda Cajal, Marta Vilaseca, Francesc Rabanal

Pharmaceutics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis